| Affiliation: | 1. Department of Medical Oncology, Multidisciplinary NET Group, Umbria Regional Cancer Network and University of Perugia, Perugia, Italy;2. Department of Oncology, San Luigi Hospital, Orbassano, Italy;3. Department of Medical Oncology, Royal Free Hospital and University College London, London, UK;4. Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK;5. Pneumologie, CHU Toulouse, Université Paul Sabatier, Toulouse, France;6. Medical Oncology, CHRU Lille, Lille, France;7. Pneumologie, Centre Hospitalier Universitaire, Rennes, France;8. Medical Oncology, University of Brescia, Brescia, Italy;9. Molecular Cancer Therapy, University of Naples Federico II, Naples, Italy;10. Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands;11. Department of Hepatology & Gastroenterology, Aarhus University Hospital, Aarhus, Denmark;12. Department of Medical Oncology, Hospices Civils de Lyon, Lyon, France;13. Evangelische Lungenklinik Berlin, Thoracic Oncology, Berlin, Germany;14. Department of Medical Oncology, SM Misericordia Hospital, Perugia, Italy;15. Medical Oncology, University Hospital of Parma, Parma, Italy;p. Oncology, Hospital La Paz Madrid, Madrid, Spain;q. Clinical Oncology, Gartnavel General Hospital, Glasgow, UK;r. Novartis Farma SpA, Origgio, Italy;s. Cognizant Technology Solutions, Mumbai, India;t. Novartis Pharma Services Inc, Belgrade, Serbia;u. Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden;v. Endocrine Oncology and Nuclear Medicine, Institut Gustave Roussy, Villejuif, France |
